Executive Change: Alterome Therapeutics Inc. Appoints Johanna Mylet as Chief Financial Officer

San Diego, CA – Alterome Therapeutics Inc. has announced the appointment of Johanna Mylet as Chief Financial Officer. About Alterome Therapeutics Inc.: Alterome Therapeutics Inc. is a clinical-stage precision oncology company focused on developing next-generation, small molecule targeted therapies for cancer. The company says it is built on rigorous science and relentless execution, and it aims to create alteration-specific therapeutics that address validated oncogenic drivers. Its pipeline includes programs designed to precisely target cancer-driving mutations while sparing healthy cells, reflecting a strategy centered on precision medicine. Alterome also presents itself as a biopharmaceutical company advancing its work in clinical development and providing dedicated contact channels for general information and clinical trials. Based in San Diego, it positions itself as a focused oncology innovator working on therapies for patients with limited treatment options.

For more information visit: https://www.alterome.com/

Alterome Therapeutics Inc.
13480 Evening Creek Drive North Suite 450
San Diego, CA 92128
Phone: 650-493-9300
LinkedIn: https://www.linkedin.com/company/alterome

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved